Adverse Occurrence type:
Alerting signals, symptoms, evidence of occurrence:
The pre-transplant leukemia was of T cell origin whereas the post-transplant relapse leukemia was of B cell origin
Demonstration of imputability or root cause:
The recurrence was shown to be in donor cells by analysis of chromosomes and restriction fragment length polymorphisms.